Bozitinib, also known as vebreltinib, is an orally bioavailable small-molecule inhibitor of the proto-oncogene c-Met (hepatocyte growth factor receptor). It selectively binds to c-Met, disrupting its signal transduction pathways and inducing cell death in tumor cells that overexpress or have constitutively activated c-Met.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1440964-89-5
Capmatinib hydrochloride
c-Met inhibitor active pharmaceutical ingredient
Ledipasvir acetone
active pharmaceutical ingredient
Ripretinib
kinase inhibitor active pharmaceutical ingredient
(1S,4R)-4-(2-Amino-6-(cyclopropylamino)-7-oxido-9H-purin-9-yl)-2-cyclopentene-1-methanol
Abacavir impurity reference standard
Landiolol hydrochloride
active pharmaceutical ingredient
6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine
QHXLXUIZUCJRKV-UHFFFAOYSA-N
CN1C=C2C=C(C(=CC2=N1)F)C(C3=NN=C4N3N=C(C=C4)C5=CN(N=C5)C6CC6)(F)F